In AD brains, tau phosphorylation levels are 3–4-fold higher compared to non-demented adult brains (19, 20), and phosphorylation facilitates tau aggregation, causing cell morphology, functionality, and viability disruption. Here, MAPT is linked to Alzheimer disease.